Want to see TSE:VHI full AI Analyst Report?
VHI Stock Chart & Stats
C$6.58
C$0.27(4.10%)
At close: 4:00 PM EDT
C$6.58
C$0.27(4.10%)
Day’s Range― - ―
52-Week RangeC$6.46 - C$13.81
Previous CloseN/A
Volume275.04K
Average Volume (3M)148.97K
Market Cap
C$500.97M
Enterprise ValueC$326.26
Total Cash (Recent Filing)C$136.51M
Total Debt (Recent Filing)C$2.86M
Price to Earnings (P/E)66.0
Beta1.19
Next Earnings
Nov 05, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding63,414,160
10 Day Avg. Volume164,389
30 Day Avg. Volume148,972
Financial Highlights & Ratios
PEG Ratio1.48
Price to Book (P/B)2.08
Price to Sales (P/S)5.09
P/FCF Ratio70.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$12.80Price Target Upside94.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.28
Revenue Forecast (FY)C$131.42M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue BaseThe growing ARR base and high recurring revenue mix improve revenue visibility, customer retention economics and operating leverage. This supports more predictable cash generation while allowing Vitalhub to expand software usage across healthcare organizations.
Balance Sheet And LiquidityMinimal leverage and substantial liquidity reduce financial risk and give Vitalhub flexibility to fund product investment, pursue complementary acquisitions and withstand temporary volatility without relying heavily on external financing.
Profitability And Integration SynergiesImproving EBITDA alongside completed integration work indicates that Vitalhub is capturing scale and acquisition synergies. Sustained gross margins near 75% and a targeted high-20s EBITDA margin could strengthen future cash conversion.
Bears Say
U.K. Contract UncertaintyDependence on public-sector procurement and the unresolved NHS contract creates a structural customer-retention and sales-cycle risk in the U.K. Further decisions could reduce ARR or delay deployments beyond the immediate quarter.
Moderating Growth And Low ROESlower organic revenue growth limits near-term operating leverage, while low ROE indicates the sizeable equity base is not yet producing strong shareholder returns. Sustained improvement will require better growth, asset utilization or profitability.
Margin And Cash Flow VariabilityServices mix and project timing can pressure margins, while the historical variability of operating and free cash flow makes results less predictable. This may complicate forecasting and reduce the consistency of funding for expansion.
Vitalhub News
VHI FAQ
What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was C$6.46 and its highest was C$13.81 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is C$500.97M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s upcoming earnings report date is Nov 05, 2026 which is in 79 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on Aug 06, 2026. The company reported C$0.03 earnings per share for the quarter, missing the consensus estimate of C$0.071 by -C$0.041.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.07.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,414,160 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of C$0.03 in its last earnings report, missing expectations of C$0.071. Following the earnings report the stock price went up 12.074%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in TSE:VHI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitalhub Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$12.80 (94.53% Upside)
C$12.80 (94.53% Upside)
Blogger Sentiment
Bullish
TSE:VHI Sentiment 100%
Sector Average 61%
Sector Average 61%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.7%
Last 30 Days ▲ 8.2%
Last 30 Days ▲ 8.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.33%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
37.72%
Trailing 12-Months
Company Description
Vitalhub
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Incorporated in 2010, Vitalhub is headquartered in Toronto, Canada.
VHI Stock 12 Month Forecast
Average Price Target
C$12.80
▲(94.53% Upside)
Technical Analysis
Diagnos
―
―
nDatalyze Corp
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―